Hopefully someone, perhaps Chicagoest, can give us a POV on the MD & A and specifically how the current cash position and debt position reconciles with the USD$87 million debt retirement and the USD$8 million FROR provided from Hepalink.
The cost of retiring the loan was USD$68.8 million. Perhaps there was accrued interest on top of this? There was also $12 million in short term debt as I recall.
Thoughts? Implications?
Thanks
ToinvÂ